Immuneering (IMRX)
NASDAQ:IMRX
US Market
Holding IMRX?
Track your performance easily

Immuneering (IMRX) Financial Statements

278 Followers

Immuneering Financial Overview

Immuneering's market cap is currently ―. The company's EPS TTM is $-1.907; its P/E ratio is -1.00; Immuneering is scheduled to report earnings on March 5, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-$ 19.20K---
Gross Profit-$ 19.20K---
EBIT$ -14.08M$ -14.31M$ -16.30M$ -13.93M$ -12.19M
EBITDA$ -13.74M$ -14.28M$ -16.21M$ -13.84M$ -11.81M
Net Income Common Stockholders$ -14.08M$ -14.31M$ -15.08M$ -12.60M$ -12.19M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 59.73M$ 71.28M$ 85.67M$ 97.24M$ 108.99M
Total Assets$ 77.09M$ 87.98M$ 102.58M$ 113.88M$ 124.90M
Total Debt$ 4.31M$ 4.38M$ 4.46M$ 4.54M$ 4.64M
Net Debt$ -55.42M$ -66.90M$ -81.20M$ -92.70M$ -104.34M
Total Liabilities$ 10.78M$ 9.26M$ 12.01M$ 9.86M$ 9.79M
Stockholders Equity$ 66.31M$ 78.72M$ 90.58M$ 104.02M$ 115.10M
Cash Flow-
Free Cash Flow$ -11.56M$ -15.53M$ -11.95M$ -12.08M$ -10.84M
Operating Cash Flow$ -11.53M$ -15.49M$ -11.78M$ -12.03M$ -10.75M
Investing Cash Flow$ 4.97M$ 21.39M$ 3.13M$ -23.97M$ 9.16M
Financing Cash Flow-$ 979.92K$ 7.83K$ 21.45K$ 28.17M
Currency in USD

Immuneering Earnings and Revenue History

Immuneering Debt to Assets

Immuneering Cash Flow

Immuneering Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis